« Redesigned Gleevec Curbs Heart Related Complications | Main | Takeda Pharmaceuticals' Actos Gets Stronger FDA Warning »

Dec 5
FDA Updates Black Box Warning for Antidepressants

In May, 2007 the U. S. Food and Drug Administration updated the black box warning on 36 antidepressants to include the increased risk of suicidal thinking and behavior, known as suicidality, in young adults between the ages of 18 and 24 during intital treatment, generally the first one or two months.

"Today's actions represent FDA's commitment to a high level of post-marketing evaluation of drug products," said Steven Galson, M.D., MPH, director of FDA's Center for Drug Evaluation and Research. "Depression and other psychiatric disorders can have significant consequences if not appropriately treated. Antidepressant medications benefit many patients, but it is important that doctors and patients are aware of the risks."

 

Anafranil (clomipramine) 
Asendin (amoxapine)
Aventyl (nortriptyline)
Celexa (citalopram hydrobromide) 
Cymbalta (duloxetine) 
Desyrel (trazodone HCl)
Elavil (amitriptyline) 
Effexor (venlafaxine HCl)
Emsam (selegiline)
Etrafon (perphenazine/amitriptyline)
fluvoxamine maleate
Lexapro (escitalopram oxalate)
Limbitrol (chlordiazepoxide/amitriptyline) 
Ludiomil (maprotiline) 
Marplan (isocarboxazid)
Nardil (phenelzine sulfate) 
nefazodone HCl
Norpramin (desipramine HCl) 
Pamelor (nortriptyline) 
Parnate (tranylcypromine sulfate) 
Paxil (paroxetine HCl) 
Pexeva (paroxetine mesylate) 
Prozac (fluoxetine HCl)
Remeron (mirtazapine) 
Sarafem (fluoxetine HCl) 
Seroquel (quetiapine)
Sinequan (doxepin)
Surmontil (trimipramine) 
Symbyax (olanzapine/fluoxetine)
Tofranil (imipramine) 
Tofranil-PM (imipramine pamoate) 
Triavil (perphenazine/amitriptyline)
Vivactil (protriptyline) 
Wellbutrin (bupropion HCl)
Zoloft (sertraline HCl) 
Zyban (bupropion HCl)

[Source: U.S. Food and Drug Administration]


2 Comments/Trackbacks




» Drug Warnings and Withdrawls for 2007 from PharmaGazette
FiercePharma has compiled a list of the top 10 drugs to have who have had approval either withdrawn or been forced to add stronger warning labels, by the FDA, with respect to their pharmaceutical products.  The list is based on 2006 worl... [Read More]

» DOJ Investigation of Paxil Widens from PharmaGazette
The U.S. Department of Justice confirmed that its investigation into whether GlaxoSmithKline withheld data concerning adverse risk associated with Paxil has been expanded to include the U.S. attorney's office in Boston and is being coordinated in W... [Read More]

submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« Redesigned Gleevec Curbs Heart Related Complications | Main | Takeda Pharmaceuticals' Actos Gets Stronger FDA Warning »

Advertise

Watch the Digital Health Revolution


sponsored ads



subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

Know More Media - Health Care / Pharmaceutical / Fitness

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

BrainBasedBusiness

TheInsurancePolicy

MarketingBlurb